MedXCell is a European cell therapy venture builder with a strong industrial mindset and a global perspective. Our focus is on technologies, techniques or novel applications in major diseases such as cancer, autoimmune, neurological and degenerative disorders. Established in 2018, we have offices in Switzerland, the EU (France) and the US (Cambridge, MA) and a multidisciplinary expert team with entrepreneurial, clinical, operational, business development and funding capabilities.
Company Details
- Employees
- 8
- Founded
- 2016
- Address
- Avenue Des Planches 20c, Montreux,vaud 1820,switzerland
- Industry
- Biotechnology
- Website
- medxcell.ch
- Keywords
- Biotechnology, Cell Therapy, Immunotherapy, NK Cells, Mesenchymal Stromal Cells, Immuno-oncology, Osteoarthritis.
- HQ
- Montreux, Vaud
Medxcell Sa Questions
Medxcell Sa's website is medxcell.ch
Medxcell Sa's LinkedIn profile is https://ch.linkedin.com/company/medxcell-sa
Medxcell Sa has
8 employees.
View email and phone details for 8
employees at Medxcell Sa.
Medxcell Sa's industry is
Biotechnology
Medxcell Sa's top competitors are
Home Biosciences,
Cytea Bio,
Organips,
Cilcare,
Medincell,
Soteria Bio,
Ingraalys,
Stem Genomics,
Medxcell Science,
Emercell.
Medxcell Sa's categories are Biotechnology
Medxcell Sa's founding year is 2016
